These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38707866)

  • 1. Impact of liquid sublingual immunotherapy on asthma onset and progression in patients with allergic rhinitis: a nationwide population-based study (EfficAPSI study).
    Demoly P; Molimard M; Bergmann JF; Delaisi B; Gouverneur A; Vadel J; Collin C; Girard L; Scurati S; Devillier P
    Lancet Reg Health Eur; 2024 Jun; 41():100915. PubMed ID: 38707866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A successful linkage of a named patient products of sublingual immunotherapy-dispensing registry to French healthcare insurance database (SNDS): methodological constitution of the EfficAPSI cohort.
    Devillier P; Molimard M; Bergmann JF; Delaisi B; Gouverneur A; Vadel J; Collin C; Girard L; Scurati S; Demoly P
    Expert Rev Clin Immunol; 2024 Apr; 20(4):405-412. PubMed ID: 38112340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sublingual immunotherapy provides long-term relief in allergic rhinitis and reduces the risk of asthma: A retrospective, real-world database analysis.
    Zielen S; Devillier P; Heinrich J; Richter H; Wahn U
    Allergy; 2018 Jan; 73(1):165-177. PubMed ID: 28561266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term real-world effectiveness of allergy immunotherapy in patients with allergic rhinitis and asthma: Results from the REACT study, a retrospective cohort study.
    Fritzsching B; Contoli M; Porsbjerg C; Buchs S; Larsen JR; Elliott L; Rodriguez MR; Freemantle N
    Lancet Reg Health Eur; 2022 Feb; 13():100275. PubMed ID: 34901915
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Real-World Adherence and Evidence of Subcutaneous and Sublingual Immunotherapy in Grass and Tree Pollen-Induced Allergic Rhinitis and Asthma.
    Vogelberg C; Brüggenjürgen B; Richter H; Jutel M
    Patient Prefer Adherence; 2020; 14():817-827. PubMed ID: 32494127
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Grass pollen sublingual immunotherapy tablets provide long-term relief of grass pollen-associated allergic rhinitis and reduce the risk of asthma: findings from a retrospective, real-world database subanalysis.
    Devillier P; Wahn U; Zielen S; Heinrich J
    Expert Rev Clin Immunol; 2017 Dec; 13(12):1199-1206. PubMed ID: 29072507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sublingual immunotherapy for asthma.
    Fortescue R; Kew KM; Leung MST
    Cochrane Database Syst Rev; 2020 Sep; 9(9):CD011293. PubMed ID: 32926419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma.
    Brunton S; Nelson HS; Bernstein DI; Lawton S; Lu S; Nolte H
    Postgrad Med; 2017 Aug; 129(6):581-589. PubMed ID: 28326908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Executive Summary of Clinical Practice Guideline on Immunotherapy for Inhalant Allergy.
    Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
    Otolaryngol Head Neck Surg; 2024 Mar; 170(3):635-667. PubMed ID: 38408153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Practice Guideline: Immunotherapy for Inhalant Allergy.
    Gurgel RK; Baroody FM; Damask CC; Mims JW; Ishman SL; Baker DP; Contrera KJ; Farid FS; Fornadley JA; Gardner DD; Henry LR; Kim J; Levy JM; Reger CM; Ritz HJ; Stachler RJ; Valdez TA; Reyes J; Dhepyasuwan N
    Otolaryngol Head Neck Surg; 2024 Mar; 170 Suppl 1():S1-S42. PubMed ID: 38408152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world, long-term effectiveness of allergy immunotherapy in allergic rhinitis: Subgroup analyses of the REACT study.
    Contoli M; Porsbjerg C; Buchs S; Larsen JR; Freemantle N; Fritzsching B
    J Allergy Clin Immunol; 2023 Aug; 152(2):445-452.e4. PubMed ID: 36871918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of Sublingual Immunotherapy in the Treatment of HDM-Induced Nasobronchial Allergies: A 3-Year Randomized Case-Control Study From Kashmir.
    Baba SM; Rasool R; Gull A; Qureshi TA; Beigh AH; Qadri Q; Shah ZA
    Front Immunol; 2021; 12():723814. PubMed ID: 34721385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
    Calderon MA; Casale TB; Nelson HS; Demoly P
    J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The MaDo real-life study of dose adjustment of allergen immunotherapy liquid formulations in an indication of respiratory allergic disease: Reasons, practices, and outcomes.
    Thétis-Soulié M; Hosotte M; Grozelier I; Baillez C; Scurati S; Mercier V
    Front Allergy; 2022; 3():971155. PubMed ID: 36017469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New perspectives in allergen specific immunotherapy driven by big trials with house dust mite sublingual SQ
    Vitiello G; Maltagliati L; Rossi O
    Clin Mol Allergy; 2020; 18():10. PubMed ID: 32536827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of sublingual specific immunotherapy on allergic asthma and rhinitis in children's real life.
    De Castro G; Zicari AM; Indinnimeo L; Tancredi G; di Coste A; Occasi F; Castagna G; Giancane G; Duse M
    Eur Rev Med Pharmacol Sci; 2013 Aug; 17(16):2225-31. PubMed ID: 23893190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The efficacy of sublingual specific immunotherapy in children with allergic rhinitis].
    Li P; Fa M; Huang ZH; Xie LS; Xu Y; Chen WB; Zhang JY; Zhang XR; Zhu Z; Li Q
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2016 Apr; 30(7):546-551. PubMed ID: 29871066
    [No Abstract]   [Full Text] [Related]  

  • 18. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
    Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
    Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
    [TBL] [Abstract][Full Text] [Related]  

  • 19. State of the Art: Development of a Sublingual Allergy Immunotherapy Tablet for Allergic Rhinitis in Japan.
    Ohashi-Doi K; Lund K; Mitobe Y; Okamiya K
    Biol Pharm Bull; 2020; 43(1):41-48. PubMed ID: 31902930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effects of pollen allergoid tyrosine-adsorbed subcutaneous immunotherapy on allergic rhinitis and asthma.
    Vogelberg C; Klimek L; Kruppert S; Becker S
    Clin Exp Allergy; 2024 Apr; 54(4):253-264. PubMed ID: 38146840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.